Journey Medical (DERM) Asset Utilization Ratio (2021 - 2026)
Journey Medical's (DERM) quarterly Asset Utilization Ratio came in at 0.69 in Q1 2026, up 2.88% YoY from 0.67 in Q1 2025, and up 0.98% on a QoQ basis from 0.68 in Q4 2025.
Journey Medical (DERM) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Journey Medical (DERM) has 6 years of Asset Utilization Ratio data on file, last reported at 0.69 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 2.88% year-over-year to 0.69 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.69 (up 2.88% YoY) and the FY2025 annual result came in at 0.71, up 0.81% from the prior year.
- Asset Utilization Ratio improved to 0.69 in Q1 2026, from 0.68 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.18 in Q2 2024 to a low of 0.62 in Q1 2023.
- A 5-year average of 0.8 and a median of 0.69 in 2026 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2024 — Asset Utilization Ratio soared 78.94% — and 2025, when it plunged 43.44%.
- Tracing DERM's Asset Utilization Ratio over 5 years: stood at 0.67 in 2022, then surged by 65.79% to 1.11 in 2023, then slumped by 30.88% to 0.76 in 2024, then slipped by 10.84% to 0.68 in 2025, then gained by 0.98% to 0.69 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.69 (Q1 2026), 0.68 (Q4 2025), and 0.69 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | 0.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.72 |
| Mar 31, 2026 | 0.69 |
| Dec 31, 2025 | 0.68 |
| Sep 30, 2025 | 0.69 |
| Jun 30, 2025 | 0.67 |
| Mar 31, 2025 | 0.67 |
| Dec 31, 2024 | 0.76 |
| Sep 30, 2024 | 0.89 |
| Jun 30, 2024 | 1.18 |
| Mar 31, 2024 | 1.11 |
| Dec 31, 2023 | 1.11 |
| Sep 30, 2023 | 1.17 |
| Jun 30, 2023 | 0.74 |
| Mar 31, 2023 | 0.62 |
| Dec 31, 2022 | 0.67 |
| Sep 30, 2022 | 0.66 |
| Jun 30, 2022 | 0.65 |
| Mar 31, 2022 | 0.67 |
| Dec 31, 2021 | 0.68 |